Key techniques and outcome research for therapeutic effect of traditional Chinese medicine as complex intervention based on holistic system and pattern differentiation & prescription

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1) Comply with IBS C Roman IV diagnostic standard;
•2) Aged between 18 and 70 years, gender is not limited;
•3) Have not taken any medication related to the disease within at least one week before entering the study, and have not participated in any other ongoing study;
•4) Colonoscopy was performed within 1 year (colon polyps, inflammatory bowel disease and other organic lesions were excluded);
•5) Voluntary subject and informed consent signed by the participant;
•6) Frequent residence in the location of treatment is conducive to treatment and follow-up.

•1) Alternate diarrhea and constipation with IBS;
•2) Patients with previous heart, liver and kidney tumors and organic lesions or patients with mental illness;
•3) Patients with previous gastrointestinal tumors and organic lesions, such as pancreatitis, intestinal polyps (not including polypectomy for more than half a month), intestinal diverticulum, history of colon or rectal cancer, inflammatory bowel history, intestinal tuberculosis, etc.;
•4) Previous metabolic diseases affecting digestive tract motility, such as thyroid disease and diabetes mellitus;
•5) People with previous gastrocardiac syndrome and lactase deficiency;
•6) Allergic constitution or allergic to the components of the drug under study;
•7) Pregnant or lactating women, and female patients with recent family planning;
•8) Previous abdominal or pelvic surgery, such as cholecystectomy;
•9) People who are taking other Chinese medicine for treatment;
•10) According to the researchers' judgment, patients with conditions that reduce the possibility of enrolment or complicate enrolment, such as frequent changes in work environment, are prone to loss of follow-up.

发起方

Beijing University of Chinese Medicine